These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 12687331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes.
    Cabrera-Rode E, Molina G, Arranz C, Vera M, González P, Suárez R, Prieto M, Padrón S, León R, Tillan J, García I, Tiberti C, Rodríguez OM, Gutiérrez A, Fernández T, Govea A, Hernández J, Chiong D, Domínguez E, Di Mario U, Díaz-Díaz O, Díaz-Horta O.
    Autoimmunity; 2006 Jun; 39(4):333-40. PubMed ID: 16891222
    [Abstract] [Full Text] [Related]

  • 5. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG.
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.
    Bingley PJ, Gale EA, European Nicotinamide Diabetes Intervention Trial (ENDIT) Group.
    Diabetologia; 2006 May; 49(5):881-90. PubMed ID: 16514546
    [Abstract] [Full Text] [Related]

  • 8. Intervention with nicotinamide in pre-type 1 diabetes: the Deutsche Nikotinamid Interventionsstudie-DENIS.
    Lampeter EF.
    Diabete Metab; 1993 May; 19(1 Pt 2):105-9. PubMed ID: 8314411
    [Abstract] [Full Text] [Related]

  • 9. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.
    Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP, DPT-1 Participating Investigators.
    Diabetes; 2001 Aug; 50(8):1735-40. PubMed ID: 11473032
    [Abstract] [Full Text] [Related]

  • 10. [Genetic and immunologic risks for development of type 1 diabetes--experiences from an intervention trial].
    Undlien DE, Joner G, Dahl-Jørgensen K, Rønningen KS, Nicol-Smith L, Torjesen PA, Søvik O.
    Tidsskr Nor Laegeforen; 2000 Sep 30; 120(23):2799-803. PubMed ID: 11107929
    [Abstract] [Full Text] [Related]

  • 11. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
    Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G, Kolb H.
    Diabetes; 1998 Jun 30; 47(6):980-4. PubMed ID: 9604880
    [Abstract] [Full Text] [Related]

  • 12. The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort.
    Long AE, Gooneratne AT, Rokni S, Williams AJ, Bingley PJ.
    J Clin Endocrinol Metab; 2012 Feb 30; 97(2):632-7. PubMed ID: 22162482
    [Abstract] [Full Text] [Related]

  • 13. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R, Verge CF, Moromisato-Gianani RI, Yu L, Zhang YJ, Pugliese A, Eisenbarth GS.
    J Autoimmun; 1996 Jun 30; 9(3):423-5. PubMed ID: 8816981
    [Abstract] [Full Text] [Related]

  • 14. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG.
    Exp Clin Endocrinol Diabetes; 1999 Jun 30; 107(8):496-505. PubMed ID: 10612480
    [Abstract] [Full Text] [Related]

  • 15. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG.
    Horm Metab Res; 1999 Oct 30; 31(10):564-9. PubMed ID: 10596966
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT).
    Bingley PJ, Mahon JL, Gale EA, European Nicotinamide Diabetes Intervention Trial Group.
    Diabetes Care; 2008 Jan 30; 31(1):146-50. PubMed ID: 17959864
    [Abstract] [Full Text] [Related]

  • 17. Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: identification by the Diabetes Prevention Trial-type 1.
    Greenbaum CJ, Schatz DA, Cuthbertson D, Zeidler A, Eisenbarth GS, Krischer JP.
    J Clin Endocrinol Metab; 2000 Mar 30; 85(3):1255-60. PubMed ID: 10720072
    [Abstract] [Full Text] [Related]

  • 18. Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes.
    Eskola V, Vähäsalo P, Akerblom HK, Knip M, Finnish ENDIT Study Group.
    Horm Res; 2003 Mar 30; 59(4):195-200. PubMed ID: 12649574
    [Abstract] [Full Text] [Related]

  • 19. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec 30; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 20. ICA+ relatives with DQA1*0102/DQB1*0602 have expected 0602 sequence and DR types.
    Greenbaum CJ, Gaur LK, Noble JA.
    J Autoimmun; 2002 Feb 30; 18(1):67-70. PubMed ID: 11869048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.